HSPB1 and breast carcinoma: In contrast, Kanagabasai et al. found that Hsp27 overexpression resulted in the reversal of doxorubicin resistance in doxorubicin-resistant MCF-7 breast cancer cells by downregulating MDR1/P-gp expression.